Liminatus Pharma Surges Over 5% After Announcing $500M BNB Investment Strategy

TradingKey – On Monday, July 28, Nasdaq-listed Liminatus Pharma Inc. (LIMN) jumped 5.28% in pre-market trading after unveiling plans to launch a dedicated crypto subsidiary focused on Binance Coin (BNB).

Liminatus Pharma Stock Chart – Source: Google

Liminatus, a preclinical-stage cancer immunotherapy company, announced it will form a new subsidiary called “American BNB Strategy” to manage and invest in BNB, the native token of the Binance ecosystem.

• The company aims to raise up to $500 million, deploying funds in phased investments targeting long-term BNB accumulation
• This move positions Liminatus alongside other corporate BNB holders like Nano Labs (NA), which currently holds 128,000 BNB

Coincidentally, the price of BNB soared above $850 today, setting a new record high. In the past 24 hours, BNB rose by more than 6%, reaching a high of $859 and temporarily reported at $849.

BNB price chart (1 hour), source: TradingView